George T. Tkalcevic

Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

Bruce D. Cohen, Deborah A. Baker, Catherine Soderstrom et al. · Clinical Cancer Research · 2005 · 362 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Identification of Estrogen Receptor β2, A Functional Variant of Estrogen Receptor β Expressed in Normal Rat Tissues

Donna N. Petersen, George T. Tkalcevic, Petra Koza‐Taylor et al. · Endocrinology · 1998 · 309 citations

Life Sciences, Endocrinology, Molecular Biology +12

Targeted Disruption of the Osteoblast/Osteocyte Factor 45 Gene (OF45) Results in Increased Bone Formation and Bone Mass

Lori C. Gowen, Donna N. Petersen, Amy L. Mansolf et al. · Journal of Biological Chemistry · 2003 · 297 citations · Full text

Medicine, Genetics, Molecular Biology +14

Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened

Michael J. Munchhof, Qifang Li, Andrei Shavnya et al. · ACS Medicinal Chemistry Letters · 2011 · 160 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451

W. Gregory Roberts, Pamela Whalen, Erik Söderström et al. · Cancer Research · 2005 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17